Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer
Authors:
- 9 September 2012
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 139 (1) , 97-106
Abstract
DKK3 is a target of methylation in various cancers and has been studied by a non-quantitative method. We assessed the quantitative methylation levels of DKK3 in cervical carcinoma, determined the potential clinical correlations, and tested whether the combination of clinical and epigenetic factors augmented the prediction power of prognosis. Sixty-two patients with cervical squamous cell carcinoma were included in this study. Quantitative methylation levels were evaluated by pyrosequencing. Clinical and pathologic findings were obtained from medical records. Survival data were analyzed using Kaplan–Meier estimates and compared with the log-rank test. The best clinico-epigenetic combinations were found using the Cox proportional hazard model. Four of five CpG positions of DKK3 were strongly methylated in cervical carcinoma compared to normal controls (p = 0.0048). The methylation in positions 1 and/or 2 were stronger in patients with higher serum levels of the SCC tumor marker and/or larger tumors (p = 0.01). The patients with a methylation level ≥26.3 % at position 1 had a lower survival rate than the patients with methylation levels at position 1 that were p = 0.03). The combination of methylation level of position 1, position 3, age, parametrial invasion, and lymphovascular space invasion (LVSI) have a significant correlation with survival (p = 0.0006). Recurrence was significantly related to the combination of methylation level of position 2, position 3, age, parametrium, and LVSI (p = 0.0041). DKK3 methylation is unfavorable to prognosis. This study defined a threshold level of methylation associated with recurrence-free survival and, furthermore, identified novel clinico-epigenetic combinations predicting disease survival or recurrence.Keywords
This publication has 26 references indexed in Scilit:
- Dkk3, downregulated in cervical cancer, functions as a negative regulator of β‐cateninInternational Journal of Cancer, 2008
- Optimization of Quantitative MGMT Promoter Methylation Analysis Using Pyrosequencing and Combined Bisulfite Restriction AnalysisThe Journal of Molecular Diagnostics, 2007
- National Cancer Incidence for the Year 2002 in KoreaCancer Research and Treatment, 2007
- Cervical cancer incidence and survival in Korea: 1993-2002International Journal of Gynecological Cancer, 2006
- Combination Analysis of Hypermethylated Wnt-Antagonist Family Genes as a Novel Epigenetic Biomarker Panel for Bladder Cancer DetectionClinical Cancer Research, 2006
- Functional Epigenomics Identifies Genes Frequently Silenced in Prostate CancerCancer Research, 2005
- Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemiaBlood, 2004
- Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to TamoxifenCancer Research, 2004
- A REIC Gene Shows Down-Regulation in Human Immortalized Cells and Human Tumor-Derived Cell LinesBiochemical and Biophysical Research Communications, 2000
- Cancer of the Uterine CervixNew England Journal of Medicine, 1996